Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription Articles published in Am J Kidney Dis Retrieve available abstracts of 48 articles: HTML format

Single Articles

November 2026
1. OUYANG Y, Ren H, Wang W, Liu N, et al
   Rituximab in IgA Nephropathy: The RITA Multicenter Randomized Trial.
   Am J Kidney Dis. 2026 Nov 7:S0272-6386(26)01199.
   PubMed     Abstract available
   
   
   
2. BU L, Vaughan LE, Said SM, Zhu Y, et al
   Proliferative Glomerulonephritis With Monotypic Immunoglobulin Deposits of IgG1 Subclass: A Case Series.
   Am J Kidney Dis. 2026 Nov 2:S0272-6386(26)01196.
   PubMed     Abstract available
   
   
   
3. THURMAN JM, Poppelaars F
   Complement in Kidney Disease: Core Curriculum 2026.
   Am J Kidney Dis. 2026;88:781-796.
   PubMed     Abstract available
   
   
   October 2026
4. BOWERS W, Garcia E, Wood N, Cater K, et al
   A Case of Bio-Dissimilarity: Rapidly Progressive Glomerulonephritis Following Switch From Infliximab to Infliximab-abda.
   Am J Kidney Dis. 2026 Oct 31:S0272-6386(26)01194.
   PubMed     Abstract available
   
   
   
5. LIU J, Li AH, Yu XJ, Lv JC, et al
   Membranoproliferative Glomerulonephritis Susceptibility Loci: A Genome-Wide Association Study.
   Am J Kidney Dis. 2026 Oct 26:S0272-6386(26)01184.
   PubMed     Abstract available
   
   
   
6. BAGCHI S, Wang J, Teixeira-Pinto A, Scholes-Robertson N, et al
   Outcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic Kidney Disease and Other Glomerular Diseases.
   Am J Kidney Dis. 2026 Oct 22:S0272-6386(26)01182.
   PubMed     Abstract available
   
   
   August 2026
7. NOROUZI S, Contreras GN
   KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis.
   Am J Kidney Dis. 2026;88:179-195.
   PubMed     Abstract available
   
   
   July 2026
8. AYOUB I, Coppock G, Wadhwani S, Yau T, et al
   KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
   Am J Kidney Dis. 2026;88:18-35.
   PubMed     Abstract available
   
   
   
9. 
   Erratum Regarding "The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease" (Am J Kidney Dis. 2024;83(1):79-89).
   Am J Kidney Dis. 2026;88:177-178.
   PubMed    
   
   
   May 2026
10. WU J, Kim D, Guo L, Wang J, et al
    Hematuria Remission and Prognosis in IgA Nephropathy: A Post hoc Analysis of The TESTING Randomized Clinical Trial.
    Am J Kidney Dis. 2026 May 28:S0272-6386(26)00935.
    PubMed    
    
    
    
11. ALMAANI S, Ayoub I, Geetha D
    KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
    Am J Kidney Dis. 2026;87:597-609.
    PubMed     Abstract available
    
    
    March 2026
12. POLLACK JS
    The Roller Coaster Ride of IgA Nephropathy.
    Am J Kidney Dis. 2026 Mar 26:S0272-6386(26)00041.
    PubMed    
    
    
    
13. REILY C, Novak J, Rizk DV
    The Roles of A Proliferation-Inducing Ligand (APRIL) and B-Cell Activating Factor (BAFF) in IgA Nephropathy.
    Am J Kidney Dis. 2026 Mar 5:S0272-6386(26)00729.
    PubMed     Abstract available
    
    
    
14. TEH JW, Stoneman S, O'Shaughnessy MM
    Complement Inhibition in Immunoglobulin A Nephropathy: A Mini-Review.
    Am J Kidney Dis. 2026;87:412-421.
    PubMed     Abstract available
    
    
    November 2025
15. DESAI NB, Gashti C, Whittier WL
    "A Change is Gonna Come" to Treatment of Lupus Nephritis: A Review.
    Am J Kidney Dis. 2025 Nov 12:S0272-6386(25)01144.
    PubMed     Abstract available
    
    
    October 2025
16. ZAND L, Fervenza FC, Sethi S
    What's New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries into Clinical Practice?
    Am J Kidney Dis. 2025 Oct 17:S0272-6386(25)01079.
    PubMed     Abstract available
    
    
    September 2025
17. BU L, Lee JH, Quigley MM, Elahimehr R, et al
    IgG3kappa Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.
    Am J Kidney Dis. 2025 Sep 18:S0272-6386(25)01024.
    PubMed     Abstract available
    
    
    June 2025
18. CHUNG EY, Carter SA, Jaure A, Howell M, et al
    Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study.
    Am J Kidney Dis. 2025 Jun 17:S0272-6386(25)00908.
    PubMed     Abstract available
    
    
    May 2025
19. 
    Erratum regarding "Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three Cases" (Am J Kidney Dis. 2024;84(6):791-797).
    Am J Kidney Dis. 2025;85:666.
    PubMed    
    
    
    March 2025
20. MORELLE J, Aydin S, Debiec H, Demoulin N, et al
    Mass Spectrometry With Data-Independent Acquisition for the Identification of Target Antigens in Membranous Nephropathy.
    Am J Kidney Dis. 2025 Mar 7:S0272-6386(25)00717.
    PubMed     Abstract available
    
    
    
21. BU L, Valeri AM, Said SM, Zhu Y, et al
    IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series.
    Am J Kidney Dis. 2025 Mar 6:S0272-6386(25)00712.
    PubMed     Abstract available
    
    
    September 2024
22. FRIMAT M, Maanaoui M, Schwotzer N, Lebas C, et al
    Non-Plasmapheresis Approaches for Managing Severe Renal Thrombotic Microangiopathy: A Report of 7 Cases.
    Am J Kidney Dis. 2024 Sep 27:S0272-6386(24)00978.
    PubMed     Abstract available
    
    
    
23. FISCHMAN CJ, Holzman LB
    Identification of Nephrin Autoantibodies Signals New Chapter for Glomerular Disease.
    Am J Kidney Dis. 2024 Sep 18:S0272-6386(24)00972.
    PubMed    
    
    
    
24. ZENI L, Mescia F, Toso D, Dordoni C, et al
    Clinical Significance of the Cystic Phenotype in Alport Syndrome.
    Am J Kidney Dis. 2024;84:320-328.
    PubMed     Abstract available
    
    
    August 2024
25. DE COS M, Mosoyan G, Chauhan K, Troost JP, et al
    Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
    Am J Kidney Dis. 2024;84:205-214.
    PubMed     Abstract available
    
    
    
26. VON SAMSON-HIMMELSTJERNA FA, Kakavand N, Voran JC, Kolbrink B, et al
    Use of Immunoadsorption and Plasma Exchange for Treating Anti-Glomerular Basement Membrane Disease: Clinical Experience in Germany.
    Am J Kidney Dis. 2024;84:255-258.
    PubMed    
    
    
    July 2024
27. VOLPI S, Angelotti ML, Palazzini G, Antonelli G, et al
    Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Mutations: Report of Three Cases.
    Am J Kidney Dis. 2024 Jul 24:S0272-6386(24)00892.
    PubMed     Abstract available
    
    
    
28. IVKOVIC V, Kronbichler A, Caza TN
    "Atypical" Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?
    Am J Kidney Dis. 2024;84:127-129.
    PubMed    
    
    
    
29. CHAUVEAU B, Gibier JB, Rabant M
    In Reply to "'Atypical' Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?".
    Am J Kidney Dis. 2024;84:129.
    PubMed    
    
    
    June 2024
30. NAKAYAMA T, Kaneko H, Suzuki Y, Okada A, et al
    Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study.
    Am J Kidney Dis. 2024 Jun 19:S0272-6386(24)00832.
    PubMed     Abstract available
    
    
    
31. CORNELL LD
    Anti-Glomerular Basement Membrane Disease: Broadening the Spectrum.
    Am J Kidney Dis. 2024;83:701-703.
    PubMed    
    
    
    
32. CHAUVEAU B, Gibier JB, Olagne J, Morel A, et al
    Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
    Am J Kidney Dis. 2024;83:713-728.
    PubMed     Abstract available
    
    
    May 2024
33. SASAKI T, Tsuboi N
    Time-Varying Proteinuria in Predicting Outcome of IgA Nephropathy.
    Am J Kidney Dis. 2024 May 11:S0272-6386(24)00755.
    PubMed    
    
    
    March 2024
34. HONDA D, Okunaga I, Omote D, Inoue H, et al
    Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
    Am J Kidney Dis. 2024 Mar 22:S0272-6386(24)00685.
    PubMed     Abstract available
    
    
    February 2024
35. TANG C, Chen P, Si FL, Lv JC, et al
    Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
    PubMed     Abstract available
    
    
    January 2024
36. MIGNANO SE, Pascal V, Odioemene NE, Forehand W, et al
    Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(24)00041.
    PubMed     Abstract available
    
    
    
37. BECK LH JR
    Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(23)00995.
    PubMed    
    
    
    
38. PAUEKSAKON P, Najafian B, Alpers CE, Fogo AB, et al
    AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis.
    Am J Kidney Dis. 2024;83:e1-e2.
    PubMed    
    
    
    
39. WANG CS, Glenn DA, Helmuth M, Smith AR, et al
    Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Am J Kidney Dis. 2024;83:37-46.
    PubMed     Abstract available
    
    
    December 2023
40. MASSICOTTE-AZARNIOUCH D, Detwiler RK, Hu Y, Falk RJ, et al
    Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)01000.
    PubMed     Abstract available
    
    
    
41. RUGGENENTI P, Reinhard L, Ruggiero B, Perna A, et al
    Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
    Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00993.
    PubMed     Abstract available
    
    
    
42. CANNEY M, Gunning HM, Johnston JC, Induruwage D, et al
    Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
    Am J Kidney Dis. 2023;82:725-736.
    PubMed     Abstract available
    
    
    November 2023
43. MORTON JI, Carstensen B, McDonald SP, Polkinghorne KR, et al
    Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
    Am J Kidney Dis. 2023;82:608-616.
    PubMed     Abstract available
    
    
    September 2023
44. PODESTA MA, Trillini M, Portalupi V, Gennarini A, et al
    Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy.
    Am J Kidney Dis. 2023 Sep 28:S0272-6386(23)00838.
    PubMed     Abstract available
    
    
    
45. CASTER DJ, Lafayette RA
    The Treatment of Primary IgA Nephropathy: Change, Change, Change.
    Am J Kidney Dis. 2023 Sep 22:S0272-6386(23)00831.
    PubMed     Abstract available
    
    
    
46. AFOLABI H, Zhang BM, O'Shaughnessy M, Chertow GM, et al
    The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
    Am J Kidney Dis. 2023 Sep 18:S0272-6386(23)00797.
    PubMed     Abstract available
    
    
    
47. KEARNEY AO, Lerma E, Lin J
    Building Towards Clinical Translation: New Study Refines Genetic Architecture of IgA Nephropathy.
    Am J Kidney Dis. 2023 Sep 14:S0272-6386(23)00794.
    PubMed    
    
    
    
48. ELEY S, Morales-Alvarez MC, Vanguri VK, Chopra B, et al
    An Unusual Case of Anti-Glomerular Basement Membrane Disease and PLA2R-Associated Membranous Nephropathy After Exposure to Hydrocarbons.
    Am J Kidney Dis. 2023 Sep 13:S0272-6386(23)00793.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum